Back to search

National and Kapodistrian University of Athens

Μελέτη της δράσεως νευροτοξικών παραγόντων στην παρεγκεφαλίδα επιμύων: Επίδραση του αντινεοπλασματικού κυτοσίνη αραβινοσίδη (ara-c)

Abstract

dc:description

Cytosine arabinoside (AraC) an anticancer drug commonly used in leukemia treatment, has an impact on cerebellar function and severe motor coordination deficits are described among its side effects. In order to characterize the nature of AraC-induced cerebellar lesions in an adult animal model, we have administered i.p. 400mg/kg bw of AraC in adult male Wistar rats for 5 days. Subsequently, the animals were subjected to behavioral tests including walking pattern evaluation, rotarod, open field and Morris watermaze tests. AraC- treated rats demonstrated a disturbed walking pattern, an impaired ability to remain on the rotating rod, along with a decrease of swimming velocity in the watermaze test, implying a weaker motor learning and coordination ability in comparison to the control group. The disturbed performance in the above tests was largely prevented by co-administration of the antioxidant N-acetylcysteine (NAC) 200mg/kg p.o. In the molecular cerebellar layer of AraC - treated animals, the neurofilament (NF) immunopositive axons, stemming from basket and stellate cells, were significantly reduced. Western blotting revealed an altered proportion of the three NF isotypes (NF-H, NF-M, NF-L). Following AraC treatment, Purkinje cells exhibited an enhanced expression of the calcium buffering protein calbindin D along with an up-regulation of other proteins responding to AraC toxic insult, like GAPDH and heat shock protein 70. To investigate the impact of developmental state in the AraC - induced toxicity in the cerebellum, we have administered i.p. 200mg/kg bw of AraC in neonatal male and female Wistar rats for 3 days (during postnatal days 14-16). Nissl staining showed a decrease in the external granular layer width within the animals of the AraC group. The latter exhibited a reduced immunopositivity against GFAP, possibly as an outcome of a toxic AraC effect on glia. Western blot analysis of the cerebella of the AraC - treated neonatal male rats also revealed a statistically significant decrease in the ratio of the NF-Η isoform to the total NF content compared to non-treated controls, though to a lesser extent than in adults. Interestingly, AraC - treated neonatal female rats exhibited an increase in all three NF isoforms compared to non-treated controls, suggesting the existence of a sexual dimorphism.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Koros, Christos
  • Κόρος, Χρήστος

Subjects

dc:subject × 22

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/21973

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Koros, Christos; Κόρος, Χρήστος. Μελέτη της δράσεως νευροτοξικών παραγόντων στην παρεγκεφαλίδα επιμύων: Επίδραση του αντινεοπλασματικού κυτοσίνη αραβινοσίδη (ara-c). National and Kapodistrian University of Athens, 2007. http://hdl.handle.net/10442/hedi/21973